Value Sense
CVS
CVS Health Corporation (CVS)
Last Price$64.9(1.2%)
Market Cap$82.3B
LTM Free Cash Flow
$6,326.0M
YoY Growth
-39.1%
3Y CAGR
-26.2%
5Y CAGR
-9.4%
Stock quality & Intrinsic value
5/10
220.8% undervalued
CVS
is 220.8% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

CVS Health Corporation Free Cash Flow

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Free Cash Flow
$116.7M
($26.5M)
$1,424.4M
$1,767.0M
$1,487.0M
$2,774.0M
$3,984.0M
$4,641.0M
$3,799.0M
$6,001.0M
$6,172.0M
$7,917.0M
$6,089.0M
$6,828.0M
$10.4B
$13.4B
$15.7B
$13.5B
$10.4B
$6,326.0M
CVS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for CVS and see if it's the right time to invest.
Dive in

CVS Health Corporation (CVS) Free Cash Flow comparison analysis

General

LTM Free Cash Flow

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

CVS Health Corporation logo
CVS Health CorporationCVS
$6,326.0M
(39.1%)
(26.2%)
(9.4%)
Median Peer Set
$747.1M
(16.0%)
0.0%
0.0%
UnitedHealth Group Incorporated logo
UnitedHealth Group IncorporatedUNH
$20.7B
(19.4%)
1.3%
4.8%
Cigna Corporation logo
Cigna CorporationCI
$8,957.0M
(12.5%)
14.1%
1.2%
Elevance Health Inc. logo
Elevance Health Inc.ELV
$4,552.0M
(32.7%)
(14.5%)
(1.8%)
Humana Inc. logo
Humana Inc.HUM
$2,391.0M
(19.7%)
36.2%
(12.1%)
Oscar Health, Inc. logo
Oscar Health, Inc.OSCR
$950.3M
N/A
N/A
N/A
Molina Healthcare, Inc. logo
Molina Healthcare, Inc.MOH
$544.0M
(65.5%)
(35.7%)
8.0%
Clover Health Investments, Corp. logo
Clover Health Investments, Corp.CLOV
$128.3M
N/A
N/A
N/A
Alignment Healthcare, Inc. logo
Alignment Healthcare, Inc.ALHC
($6,648.0K)
(93.0%)
(59.1%)
N/A
Centene Corporation logo
Centene CorporationCNC
($490.0M)
N/A
N/A
N/A
Bright Health Group, Inc. logo
Bright Health Group, Inc.BHG
($2,834.8M)
N/A
254.4%
N/A

CVS key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23Dec'24
Revenue
% growth
37,006.7
21.0%
43,821.4
18.4%
76,329.5
74.2%
87,472.0
14.6%
98,215.0
12.3%
95,778.0
(2.5%)
107,080.0
11.8%
123,120.0
15.0%
126,761.0
3.0%
139,367.0
9.9%
153,290.0
10.0%
177,546.0
15.8%
184,786.0
4.1%
194,579.0
5.3%
256,776.0
32.0%
268,706.0
4.6%
292,111.0
8.7%
322,467.0
10.4%
357,776.0
10.9%
372,809.0
4.2%
Cost of Goods Sold (COGS)27,312.132,079.260,221.869,182.077,857.075,559.086,518.0100,632.0102,978.0114,000.0126,762.0148,712.0156,258.0163,041.0211,248.0219,660.0239,991.0267,965.0303,345.0321,408.0
Gross Profit
% margin
9,694.6
26.2%
11,742.2
26.8%
16,107.7
21.1%
18,290.0
20.9%
20,358.0
20.7%
20,219.0
21.1%
20,562.0
19.2%
22,488.0
18.3%
23,783.0
18.8%
25,367.0
18.2%
26,528.0
17.3%
28,834.0
16.2%
28,528.0
15.4%
31,538.0
16.2%
45,528.0
17.7%
49,046.0
18.3%
52,120.0
17.8%
54,502.0
16.9%
54,431.0
15.2%
51,401.0
13.8%
Operating Expenses7,675.19,300.611,314.412,244.013,933.014,082.014,231.015,278.015,746.016,568.017,053.018,448.018,990.027,517.033,541.035,135.038,810.046,548.040,688.041,606.0
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Selling, General & Administrative Expenses (SG&A)7,675.19,300.611,314.412,244.213,933.014,092.014,231.00.00.00.00.00.00.00.00.00.00.00.00.0(1,279.0)
Operating Income
% margin
2,019.5
5.5%
2,441.6
5.6%
4,793.3
6.3%
6,046.0
6.9%
6,425.0
6.5%
6,137.0
6.4%
6,331.0
5.9%
7,210.0
5.9%
8,037.0
6.3%
8,799.0
6.3%
9,475.0
6.2%
10,386.0
5.8%
9,538.0
5.2%
4,021.0
2.1%
11,987.0
4.7%
13,911.0
5.2%
13,310.0
4.6%
7,954.0
2.5%
13,743.0
3.8%
8,516.0
2.3%
Interest Income0.00.00.021.05.03.04.04.08.015.021.020.021.00.00.00.00.00.00.00.0
Interest Expense0.00.00.0530.0530.0539.0588.0561.0517.0615.0859.01,078.01,062.02,619.03,035.02,907.02,503.02,287.02,658.02,958.0
Pre-tax Income1,909.02,225.84,358.75,537.05,900.05,601.05,747.06,305.07,528.07,678.08,616.08,637.08,268.01,406.08,997.09,770.010,537.05,836.011,173.06,148.0
Income Tax
% effective tax rate
684.3
35.8%
856.9
38.5%
1,721.7
39.5%
2,193.0
39.6%
2,200.0
37.3%
2,179.0
38.9%
2,258.0
39.3%
2,436.0
38.6%
2,928.0
38.9%
3,033.0
39.5%
3,386.0
39.3%
3,317.0
38.4%
1,637.0
19.8%
2,002.0
142.4%
2,366.0
26.3%
2,569.0
26.3%
2,548.0
24.2%
1,509.0
25.9%
2,805.0
25.1%
1,562.0
25.4%
Net Income
% margin
1,224.7
3.3%
1,368.9
3.1%
2,637.0
3.5%
3,212.0
3.7%
3,696.0
3.8%
3,427.0
3.6%
3,462.0
3.2%
3,864.0
3.1%
4,592.0
3.6%
4,644.0
3.3%
5,237.0
3.4%
5,317.0
3.0%
6,622.0
3.6%
(594.0)
(0.3%)
6,634.0
2.6%
7,179.0
2.7%
8,001.0
2.7%
4,311.0
1.3%
8,344.0
2.3%
4,614.0
1.2%
EPS1.491.651.972.232.582.512.593.053.773.984.664.936.47(0.57)5.105.486.003.296.493.66
Diluted EPS1.451.601.922.182.552.492.573.033.743.964.634.906.44(0.57)5.085.465.953.266.473.66
EBITDA
% margin
2,608.6
7.0%
3,174.9
7.2%
5,887.9
7.7%
7,341.0
8.4%
7,819.0
8.0%
7,609.0
7.9%
7,903.0
7.4%
8,619.0
7.0%
9,915.0
7.8%
10,224.0
7.3%
11,567.0
7.5%
12,190.0
6.9%
11,809.0
6.4%
6,743.0
3.5%
16,403.0
6.4%
17,118.0
6.4%
17,526.0
6.0%
12,347.0
3.8%
18,197.0
5.1%
13,703.0
3.7%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is CVS Health Corporation's Free Cash Flow?

As of today, CVS Health Corporation's last 12-month Free Cash Flow is $6,326.0M, based on the financial report for Dec 31, 2024 (Q4’2024).

2) What is CVS Health Corporation's Free Cash Flow growth rate?

Over the last year, CVS Health Corporation's Free Cash Flow growth was (39.1%). The average annual Free Cash Flow growth rates for CVS Health Corporation have been (18.3%) over the past three years, (9.4%) over the past five years.

3) Is CVS Health Corporation's Free Cash Flow growth rate Good?

Over the last year, CVS Health Corporation's Free Cash Flow growth was (39.1%), which is lower than industry growth of (0.7%). It indicates that CVS Health Corporation's Free Cash Flow growth is Bad.

4) How does CVS Health Corporation's Free Cash Flow growth rate compare to its peers?

Over the last year, CVS Health Corporation's Free Cash Flow growth was (39.1%), which is higher than peer median growth of (67.2%). The list of peers includes UNH, CI, ELV, HUM, OSCR, MOH, CLOV, ALHC, CNC, BHG etc.